Last updated 33 days ago

Phase IIa Study Evaluating AZD7798 in Crohn's Disease

192 patients around the world
Available in Spain, Chile, Brazil, Argentina, United States, Mexico
AstraZeneca
192Patients around the world
This study is for people with
Crohn's disease
Moderate to severe crohn's disease
Requirements for the patient
To 80 Years
All Gender
Medical requirements
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy